Cyprus vs Guam: The number of people with susceptibility test result for rifampicin
Cyprus
29
in 2021
Guam
35
in 2021
Cyprus rank
128th
Guam rank
126th
The number of people with susceptibility test result for rifampicin over time
- Cyprus
- Guam
How they compare
Guam currently reports 35 against 29 in Cyprus, a difference of 6.
That makes Guam's figure about 1.2 times Cyprus's.
Across all 5 years both countries report, Guam has been ahead every year.
Cyprus ranks 128th and Guam ranks 126th of 155 countries.
Guam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | Guam | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 37.67 | 50.33 | 12.67 | Guam |
| 2020s | 27 | 36.5 | 9.5 | Guam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cyprus or Guam?
- Guam, at 35 against 29 in Cyprus as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cyprus and Guam?
- 6, with Guam ahead.
- How many years of comparable data are there for Cyprus and Guam?
- 5 years are reported by both, from 2017 to 2021.
- How do Cyprus and Guam rank globally for the number of people with susceptibility test result for rifampicin?
- Cyprus ranks 128th and Guam ranks 126th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.